Skip to main content
Premium Trial:

Request an Annual Quote

Boschwitz Joins Orchid Cellmark, Caulfield Leaves Affy, Lewent Named to Thermo Fisher Board, and More

NEW YORK (GenomeWeb News) - Orchid Cellmark has appointed Jeffrey Boschwitz to be VP of North America marketing sales. Boschwitz formerly was director of marketing, planning, analysis, and research at Quest Diagnostics, and he was a principal in Booz Allen Hamilton’s healthcare practice.
 

 
Barbara Caulfield has resigned her role as executive VP and general counsel at Affymetrix and will leave the company on June 13 to take a position with a private law firm, according to a US Securities and Exchange Commission document. She will continue to serve as secretary to the company’s board of directors. 
 
Caulfield is taking members of her legal team from Affymetrix with her to the Dewey LeBoeuf law firm.  
 
Joining Caulfield in the East Palo Alto, Calif., office of the New York-based law firm are Michael Malacek and Peter Root as partners and Stephen Holmes as counsel.
 

 
Thermo Fisher Scientific has named Judy Lewent to its board of directors and has appointed her to its Strategy Review Committee. Lewent previously was executive VP and CFO of Merck, where she worked from 1980 to 2007. Lewent also has served on the boards at Dell and at Motorola, and she is a member of the MIT Corporation and a member of the American Academy of Arts and Sciences.
 

 
Heiner Dreismann has joined Med Biogene’s board of directors and he will chair the company’s Strategy Committee. Dreismann formerly was CEO of Roche Molecular Diagnostics, where he helped to introduce the company’s PCR products, expanded their diagnostic tests, and held several positions in global business development, R&D, and manufacturing.
 

 
The US Centers for Disease Control and Prevention has added five new members to its genomics working group. The Evaluation of Genomic Applications in Practice and Prevention Working Group includes specialists in genomics, healthcare, clinical and laboratory practice, ethics, epidemiology, public health, healthcare, and other related areas.
 
The latest additions to the EWG include: Doug Campos-Outcalt of the University of Arizona’s College of Medicine; Roger Klein of the H. Lee Moffitt Cancer Center & Research Institute, and the University of South Florida College of Medicine; Kenneth Offit of Memorial Sloan-Kettering Cancer Center; Stephen Pauker of Tufts Medical Center; and David Veenstra of the University of Washington.
 
Leaving EWG are Katrina Armstrong of the University of Pennsylvania’s School of Medicine, and Kathryn Phillips of the University of California San Francisco.
 

 
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.